Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Gains from Sales and Divestitures (2018 - 2020)

Historic Gains from Sales and Divestitures for vTv Therapeutics (VTVT) over the last 3 years, with Q4 2020 value amounting to $11667.0.

  • vTv Therapeutics' Gains from Sales and Divestitures changed N/A to $11667.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $11667.0, marking a year-over-year change of. This contributed to the annual value of $11667.0 for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q4 2020, vTv Therapeutics' Gains from Sales and Divestitures is $11667.0.
  • In the past 5 years, vTv Therapeutics' Gains from Sales and Divestitures registered a high of $11667.0 during Q2 2018, and its lowest value of $11666.0 during Q1 2018.
  • Over the past 3 years, vTv Therapeutics' median Gains from Sales and Divestitures value was $11667.0 (recorded in 2018), while the average stood at $11666.6.
  • In the last 5 years, vTv Therapeutics' Gains from Sales and Divestitures dropped by 0.86% in 2019 and then grew by 0.86% in 2020.
  • Quarter analysis of 3 years shows vTv Therapeutics' Gains from Sales and Divestitures stood at $11667.0 in 2018, then fell by 0.01% to $11666.0 in 2019, then increased by 0.01% to $11667.0 in 2020.
  • Its last three reported values are $11667.0 in Q4 2020, $11667.0 for Q3 2020, and $11667.0 during Q2 2020.